Published online 17 June 2004
Nucleic Acids Research, Vol. 32 No. 11 © Oxford University Press 2004; all rights reserved
Direct labeling of RNA with multiple biotins allows sensitive expression profiling of acute leukemia class predictor genes
Affymetrix Inc., 3380 Central Expressway, Santa Clara, CA 95051, USA
* To whom correspondence should be addressed. Tel: +1 408 731 5776; Fax: +1 408 481 0422; Email: kyle_cole{at}affymetrix.com
Received November 26, 2003; Revised January 20, 2004; Accepted May 26, 2004
Direct labeling of RNA is an expedient method for labeling large quantities (e.g. micrograms) of target RNA for microarray analysis. We have developed an efficient labeling system that uses T4 RNA ligase to attach a 3'-biotinylated donor molecule to target RNA. Microarray analyses indicate that directly labeled RNA is uniformly labeled, has higher signal intensity than comparable labeling methods and achieves high transcript detection sensitivity. The labeled donor molecule we have developed allows the attachment of multiple biotins, which increases target signal intensity up to 30%. We have used this direct-labeling method to detect previously discovered class predictor genes for two types of cancer: acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In order to test the sensitivity of direct RNA labeling, we analyzed the AML and ALL expression profiles for predictor genes that were previously found to show elevated expression in the disease state. Direct labeling of AML poly(A) RNA detects 90% of the class predictor genes that are detected by the IVT-based target amplification method used to discover the genes. These results indicate that the detection sensitivity, simplicity (single tube reaction) and speed (2 h) of this direct labeling protocol may be ideal for diagnostic applications that do not require target amplification.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Liu, L. F. Sempere, F. Galimberti, S. J. Freemantle, C. Black, K. H. Dragnev, Y. Ma, S. Fiering, V. Memoli, H. Li, et al. Uncovering Growth-Suppressive MicroRNAs in Lung Cancer Clin. Cancer Res., February 15, 2009; 15(4): 1177 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bak, A. Silahtaroglu, M. Moller, M. Christensen, M. F. Rath, B. Skryabin, N. Tommerup, and S. Kauppinen MicroRNA expression in the adult mouse central nervous system RNA, March 1, 2008; 14(3): 432 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Sempere, M. Christensen, A. Silahtaroglu, M. Bak, C. V. Heath, G. Schwartz, W. Wells, S. Kauppinen, and C. N. Cole Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer Cancer Res., December 15, 2007; 67(24): 11612 - 11620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Q. Liang, W. Li, Y. Li, C.-y. Tan, J.-X. Li, Y.-X. Jin, and K.-C. Ruan An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe Nucleic Acids Res., January 31, 2005; 33(2): e17 - e17. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huber, T.-F. Wei, U. R. Muller, P. A. Lefebvre, S. S. Marla, and Y. P. Bao Gold nanoparticle probe-based gene expression analysis with unamplified total human RNA Nucleic Acids Res., October 8, 2004; 32(18): e137 - e137. [Abstract] [Full Text] [PDF] |
||||



